MitoPharm Corporation Studies Indicate That Schisandrin B Can Induce Heat Shock Protein Production in the Heart, Which Partly Explains the Mechanism Involved in the Protection Against I-R Injury

SEATTLE--(BUSINESS WIRE)--MitoPharm Corporation, Inc. (Pink Sheets:MTPM), releases the results of a research paper where Professor Dr. Robert Ko published additional findings on the biochemical mechanisms of Schisandrin B, the precursor of (-) Schisandrin B – a novel discovery by Dr. Ko – which explain the beneficial effects on Myocardial Ischemia-Reperfusion.